Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-01

Clinical Trial Update: Concurrent Bupropion / Varenicline for Smoking Cessation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the combination of bupropion and varenicline for smoking cessation has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CHANTIX (varenicline tartrate)
  • bupropion (bupropion)

Snippet

Sponsor: Duke University | Conditions: Nicotine Dependence | Phase 3 | Status: COMPLETED | Results posted: 2014-08-01